Sirna Therapeutics - Ownership and Business Overview

Life ScienceCompany

Sirna Therapeutics Ownership

Who owns Sirna Therapeutics?

Sirna Therapeutics is owned by Alnylam Pharmaceuticals. It was acquired on March 5, 2014.

Sirna Therapeutics Business Overview

Where is Sirna Therapeutics headquartered?

Sirna Therapeutics is headquartered in San Francisco, California.

How many employees does Sirna Therapeutics have?

Sirna Therapeutics has 38 employees.

What sector is Sirna Therapeutics in?

Sirna Therapeutics is a life science company.

When was Sirna Therapeutics founded?

Sirna Therapeutics was founded in 1992.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Sirna Therapeutics, Inc.

185 Berry Street Suite 6504,
San Francisco, California 94107
United States,
(415) 512-7200

Sirna Therapeutics, Inc. is a provider of research, preclinical, and/or clinical development with product candidates in various areas, including age-related macular degeneration (AMD).


 Subscribe to unlock this and 206,344
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.